Knight Therapeutics (KHTRF) 6.4020 $KHTRF Knight

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Knight Therapeutics (KHTRF) 6.4020 $KHTRF

Knight Therapeutics Inc. Announces Election of Directors
Marketwire Canada - Thu Jun 16, 5:01PM CDT
MONTREAL, QUEBEC--(Marketwired - Jun 16, 2016) - Knight Therapeutics Inc. (TSX:GUD) ("Knight" or the "Company" announced today that each director nominee listed in the Management Information Circular dated May 13, 2016 was elected as Director of the Company during the Annual Meeting of the Shareholders held in Montréal, Québec.
GUD.TO: 8.22 (-0.07)

Long Zone Holdings Announces Acquisition of Knight Therapeutics Inc. Common Shares
Marketwired - Thu Jun 02, 5:31PM CDT
MONTREAL, QUEBEC--(Marketwired - Jun 2, 2016) - Long Zone Holdings Inc. ("the Corporation" announced that pursuant to a previously announced prospectus offering ("the Offering" by Knight Therapeutics Inc. ("Knight", it has today acquired ownership of 45,000 common shares of Knight ("the Acquired Shares" representing approximately 0.03% of the outstanding common shares of Knight. The Acquired Shares were acquired at a price of $8.00 per common share for an aggregate consideration of $360,000.

Knight to Present at Both the National Bank Financial Quebec Conference in Montreal and the Jefferies Healthcare Conference in New York City
Marketwired - Tue May 31, 7:01AM CDT
MONTREAL, QUEBEC--(Marketwired - May 31, 2016) - Knight Therapeutics Inc. (TSX:GUD) ("Knight", a leading Canadian specialty pharmaceutical company, announced today that Jonathan Ross Goodman, President and CEO, is scheduled to present at the National Bank Financial Quebec Conference on Wednesday, June 1, 2016 at 2:00 pm ET at the Hotel Le Crystal in Montreal, while Jeffrey Kadanoff, CFO, is scheduled to present a corporate update at the Jefferies Healthcare Conference on Thursday, June 9, 2016 at 9:30 am ET at the Grand Hyatt New York. A copy of the Jefferies Healthcare Conference presentation will be available at www.gud-knight.com.
GUD.TO: 8.22 (-0.07)

Knight Reports First Quarter 2016 Results
Marketwire Canada - Tue May 10, 5:01AM CDT
MONTREAL, CANADA--(Marketwired - May 10, 2016) - Knight Therapeutics Inc. (TSX:GUD) ("Knight" or the "Company", a leading Canadian specialty pharmaceutical company, today reported financial results for its first quarter ended March 31, 2016. In thousands of Canadian dollars except for share and per share amounts.
GUD.TO: 8.22 (-0.07)

Knight Finds EMPAthetic Partner for Neuragen(R) in the Middle East
Marketwired - Mon Apr 25, 7:02AM CDT
Knight Therapeutics Inc. (TSX: GUD), through one of its wholly-owned subsidiaries ("Knight", announced today that it has entered into an exclusive distribution agreement with EMPA Healthcare LLC ("EMPA" to commercialize Neuragen(R), a topical natural health product used to relieve the symptoms of peripheral nerve pain, in the United Arab Emirates and Kuwait. EMPA will also have non-exclusive distribution rights in the other Gulf Cooperation Council ("GCC" countries. Knight may extend exclusivity on a country-by-country basis should certain minimum sales targets be met in each GCC country. Knight sold the rights to Neuragen(R) in the U.S. in June 2015 and retains the rights for all other territories.
GUD.TO: 8.22 (-0.07)

Knight Receives NOD from Health Canada for ATryn(R)
Marketwired - Mon Apr 25, 7:02AM CDT
Knight Therapeutics Inc. (TSX: GUD) ("Knight", a leading Canadian specialty pharmaceutical company, today announced that it has received a Notice of Deficiency ("NOD" for its ATryn(R) New Drug Submission.
GUD.TO: 8.22 (-0.07)

Knight Blooms at Healthcare Investor Conference in Toronto
Marketwired - Mon Apr 25, 7:02AM CDT
Knight Therapeutics Inc. (TSX: GUD) ("Knight", a leading Canadian specialty pharmaceutical company, announced today that Mr. Jonathan Ross Goodman, President and CEO, and Mr. Jeffrey Kadanoff, CFO, are scheduled to present a corporate update at the Bloom Burton & Co. Healthcare Investor Conference on Monday, May 2, 2016 at 1:30 pm ET at the Sheraton Centre Toronto Hotel. A copy of the presentation will be available at www.gud-knight.com.
GUD.TO: 8.22 (-0.07)

Knight Therapeutics CFO Jeffrey Kadanoff at Cercle Finance et Placement du Québec on April 19
CNW Group - Wed Apr 13, 9:30AM CDT
Members of the media are invited to a presentation by Jeffrey Kadanoff, Chief Financial Officer of Knight Therapeutics, who will be the guest speaker at Le Cercle finance et placement du Québec's next luncheon conference, to be held on Tuesday, April 19. Please note that the presentation will be in French.

Knight Reports Fourth Quarter and Year-Ended December 31, 2015 Results
Marketwired - Thu Mar 24, 5:01AM CDT
Knight Therapeutics Inc. (TSX: GUD) ("Knight" or the "Company", a leading Canadian specialty pharmaceutical company, today reported financial results for its fourth quarter and year-ended December 31, 2015.
GUD.TO: 8.22 (-0.07)

Knight Receives Dividend From Medison
Marketwired - Wed Mar 23, 7:02AM CDT
Knight Therapeutics Inc. (TSX: GUD), through one of its wholly-owned subsidiaries ("Knight", announced today receipt of a NIS 7.1 million ($2.4 million) dividend from Medison Biotech (1995) Ltd. ("Medison". Knight owns 28.3% of Medison, Israels 4th largest specialty pharma company ranked by revenue.
GUD.TO: 8.22 (-0.07)

Knight Partner Profounda Inc. Launches Impavido in U.S.
Marketwired - Tue Mar 22, 7:04AM CDT
Knight Therapeutics Inc. (TSX: GUD), through one of its wholly-owned subsidiaries ("Knight", announced today that its U.S. commercialization partner, Profounda Inc. ("Profounda", has launched Impavido® (miltefosine) in the United States. Impavido® is the first and only oral treatment for visceral, mucosal and cutaneous leishmaniasis approved by the U.S. Food and Drug Administration ("FDA".
GUD.TO: 8.22 (-0.07)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 347

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 137

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 303

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
UAE Ties Diplomacy, Media and AI Into a Shared Signal

Updated Category News Views 128

Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 270

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 332

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 386

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 518

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 513

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 348

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Voting Rights and Shareholder Engagement

Updated Category News Views 81

Understanding Voting Rights and Shareholder Engagement In today's corporate landscape, voting rights play a crucial role in corporate governance. Companies are required to disclose their voting rights and the number of shares, allowing shareholders to engage meaningfully with the management. This article will delve into the intricacies of voting rights, and the relevant...

Continue Reading
Cornish Metals Advances with Court Approval for UK Transition

Updated Category News Views 160

Cornish Metals Gets Final Court Approval for UK Move Cornish Metals Inc. (AIM/TSXV: CUSN) is thrilled to share that it has obtained a final order from the Ontario Superior Court of Justice. This landmark decision supports the company's plan to re-domicile from Canada to the United Kingdom through a statutory plan of arrangement, thus paving the way for an exciting new...

Continue Reading
Labubu's Rise: Challenging Mattel's Barbie in Toy Industry

Updated Category News Views 221

Pop Mart's Labubu Surges Towards Billion-Dollar Success Mattel Inc.'s iconic dolls, including Barbie and Hot Wheels, find themselves in a competitive landscape transformed by Pop Mart's innovative Labubu toy brand. This vibrant brand is racing towards remarkable financial achievements, aiming for a valuation that could reach four billion dollars by the year’s end. The...

Continue Reading
Tesla's Elusive Recovery in China: Challenges and Market Shift

Updated Category News Views 356

Tesla's Delivery Challenges in China Tesla Inc (NASDAQ: TSLA) recently faced a notable setback with a 13.5% year-over-year decline in vehicle deliveries during the second quarter. This decline raises questions about the company's performance in the critical Chinese market, a pivotal source for deliveries. The Decline in Numbers Data from the China Passenger Car...

Continue Reading
Alamos Gold Unveils Exciting Developments at PDA Project

Updated Category News Views 99

Alamos Gold Expands High-Grade Mineralization All financial figures mentioned are in United States dollars unless stated otherwise. Recently, Alamos Gold Inc. (TSX:AGI; NYSE:AGI), a prominent name in the mining industry, provided exciting updates regarding their ongoing drilling projects in the Mulatos District. The primary focus is on the Puerto Del Aire (PDA) and Cerro...

Continue Reading